Assessment of Thiopurine–based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia
For the past half century, thiopurines have earned themselves a reputation as effective anti-cancer and immunosuppressive drugs.
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Shahid Sadoughi University of Medical Sciences
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980020/ |
| id |
pubmed-3980020 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-39800202014-04-14 Assessment of Thiopurine–based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia Azimi, F Jafariyan, M Khatami, S Mortazavi, Y Azad, M Review Article For the past half century, thiopurines have earned themselves a reputation as effective anti-cancer and immunosuppressive drugs. Shahid Sadoughi University of Medical Sciences 2014 2014-03-15 /pmc/articles/PMC3980020/ /pubmed/24734162 Text en © 2014 Iranian Journal of Pediatric Hematology Oncology This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Azimi, F Jafariyan, M Khatami, S Mortazavi, Y Azad, M |
| spellingShingle |
Azimi, F Jafariyan, M Khatami, S Mortazavi, Y Azad, M Assessment of Thiopurine–based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia |
| author_facet |
Azimi, F Jafariyan, M Khatami, S Mortazavi, Y Azad, M |
| author_sort |
Azimi, F |
| title |
Assessment of Thiopurine–based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia |
| title_short |
Assessment of Thiopurine–based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia |
| title_full |
Assessment of Thiopurine–based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia |
| title_fullStr |
Assessment of Thiopurine–based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia |
| title_full_unstemmed |
Assessment of Thiopurine–based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia |
| title_sort |
assessment of thiopurine–based drugs according to thiopurine s-methyltransferase genotype in patients with acute lymphoblastic leukemia |
| description |
For the past half century, thiopurines have earned themselves a reputation as effective anti-cancer and immunosuppressive drugs. |
| publisher |
Shahid Sadoughi University of Medical Sciences |
| publishDate |
2014 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980020/ |
| _version_ |
1612075718916702208 |